Director, Brigham and Women's Hospital Cardiac Amyloidosis Program
Cardiology
Dr. Rodney H. Falk, MD
|
|
Give Review
Rodney H. Falk, MD is an expert in the field of Cardiology. He received awards:"CMS Meaningful Use Stage 1 Certification", "Super Doctor" and "Fellow (FACC)". Rodney Falk has written publications. He has 50 publications published with PubMed. The lastest paper is: 'Electrophysiologic assessment of conduction abnormalities and atrial arrhythmias associated with amyloid cardiomyopathy.' He accepts Medicare.
Publications
- Electrophysiologic assessment of conduction abnormalities and atrial Arrhythmias associated with amyloid cardiomyopathy.
- Echocardiography in cardiac amyloidosis.
- Lysosomal dysfunction and impaired autophagy underlie the pathogenesis of amyloidogenic light chain-mediated cardiotoxicity.
- Coronary Microvascular Dysfunction Is Related to Abnormalities in Myocardial Structure and Function in Cardiac Amyloidosis.
- Imaging cardiac amyloidosis: a pilot study using (18)F-florbetapir positron emission tomography.
- Left Ventricular Structure and Function in TTR-Related versus AL Cardiac Amyloidosis.
- AL amyloidosis or multiple myeloma? - an important distinction.
- Stanniocalcin1 is a key mediator of amyloidogenic light chain induced cardiotoxicity.
- Human amyloidogenic light chain proteins result in cardiac dysfunction, cell death, and early mortality in zebrafish.
- A transthyretin variant, Asp18Asn, associated with amyloid Cardiomyopathy: a new African-American variant?
- Longitudinal Strain Imaging in Light-Chain Cardiac Amyloidosis: Can it Help to Refine the Approach to Treatment?
- Senile systemic amyloidosis: are regional differences real or do they reflect different diagnostic suspicion and use of techniques?
- Letter by falk regarding article, "an unusual Heart failure: cardiac amyloidosis due to light chain myeloma".
- Current perspectives on cardiac amyloidosis.
- Cardiac amyloidosis: a treatable Disease, often overlooked.
- Clinical problem-solving. A heavy Heart.
- Prognostic significance of strain Doppler imaging in light-chain amyloidosis.
- Diagnosis and management of cardiac sarcoidosis.
- Cardiomyopathy: the importance of recognizing the uncommon diagnosis.
- Amyloid Heart disease.
- Cardiac amyloidosis in African Americans: comparison of clinical and laboratory features of transthyretin V122I amyloidosis and immunoglobulin light chain amyloidosis.
- Driving and ventricular arrhythmia: a historical perspective.
- Ethnic disparity in intracranial hemorrhage among anticoagulated patients with Atrial fibrillation: an answer in search of a question?
- Atrial fibrillation or sinus rhythm? Controversy and contradiction in quality of life outcomes.
- Quantitative serum free light chain assay in the diagnostic evaluation of AL amyloidosis.
- Is elevated plasma B-natriuretic peptide in amyloidosis simply a function of the presence of Heart failure?
- Diagnosis and management of the cardiac amyloidoses.
- Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amy...
- Senile systemic amyloidosis presenting with Heart failure: a comparison with light chain-associated amyloidosis.
- Is rate control or rhythm control preferable in patients with Atrial fibrillation? Rate control is preferable to rhythm control in the majority of patients with Atrial...
- Comparison of the strain Doppler echocardiographic features of familial amyloid polyneuropathy (FAP) and light-chain amyloidosis.
- Cardiovascular magnetic resonance in cardiac amyloidosis.
- Reconsidering combined antiplatelet and anticoagulant therapy in Atrial fibrillation.
- Improvement in quality of life of patients with AL amyloidosis treated with high-dose melphalan and autologous stem cell transplantation.
- The increasing need for anticoagulant therapy to prevent stroke in patients with Atrial fibrillation.
- High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: an 8-year study.
- Longitudinal Myocardial velocity gradient derived from pulsed Doppler tissue imaging in AL amyloidosis: a sensitive indicator of systolic and diastolic dysfunction.
- Persistent pleural effusions in primary systemic amyloidosis: etiology and prognosis.
- Comparison of sotalol versus amiodarone in maintaining stability of sinus rhythm in patients with Atrial fibrillation (Sotalol-Amiodarone Fibrillation Efficacy Trial [...
- The diagnosis and typing of cardiac amyloidosis.
- Longitudinal Myocardial function assessed by tissue velocity, strain, and strain rate tissue Doppler echocardiography in patients with AL (primary) cardiac amyloidosis.
- Adenosine-induced ventricular flutter?
- Tolerability and efficacy of thalidomide for the treatment of patients with light chain-associated (AL) amyloidosis.
- Management of Atrial fibrillation--radical reform or modest modification?
- Ventricular rate control in the elderly: is digoxin enough?
- Prognostic significance of ultrasound Myocardial tissue characterization in patients with cardiac amyloidosis.
- Identification of a novel transthyretin Thr59Lys/Arg104His. A case of compound heterozygosity in a Chinese patient diagnosed with familial transthyretin amyloidosis.
- Usefulness of pulsed tissue Doppler imaging for evaluating systolic and diastolic left ventricular function in patients with AL (primary) amyloidosis.
- The neglected entity of familial cardiac amyloidosis in African Americans.
Schools
University Of Birmingham
Birmingham Accident Hospital
Dudley Road Hospital England
Brooke General Hospital Eng
King39s College Hospital Eng
Peter Bent Brigham HospHar
Procedures Preformed
- Ablation for Treatment of Cardiac Arrhythmias
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- View All
Conditions Treated
- Aneurysm and Dissection of Heart
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Ectasia
- View All
Doctors Specialties
- Cardiology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Super Doctor
- Fellow (FACC)
Education
-
Brigham and Women's Hospital
Hospital
-
Newton-Wellesley Hospital -
Beth Israel Deaconess Medical Center -
Brigham and Women's Hospital
Drug Facts
| NPI NUMBER | 1619908902 | |
| NPPES Provider LastName | FALK | |
| NPPES Provider FirstName | RODNEY | |
| NPPES Provider ZIPCode | 022153904 | |
| NPPES Provider State | MA | |
| Specialty Description | Cardiology | |
| Total Claim Count | 754.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 12.0 | |
| Percent Opioid Claims | 1.59 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1619908902 |
| Last Name Of The Provider | FALK |
| First Name Of The Provider | RODNEY |
| View All |
Similar Doctors
|
|
Dr. Sekar Kathiresan, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Alfonso H. Waller, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Bryan P. Yan, MB BS
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Mark D. Benson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marcello Panagia, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Aaron L. Baggish, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Donald E. Cutlip, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Samuel Z. Goldhaber, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Michael J. Landzberg, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ravin Davidoff, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Santosh C. Varkey, MD
This Doctor is OpenDoctor Recommended.
|